Top

Published in:

01-01-2018 | Invited article

Cirrhosis and LI-RADS

Authors: Demetrios Papadatos, Kathryn J. Fowler, Ania Z. Kielar, Jennifer Cui, Claude B. Sirlin

Published in: Abdominal Radiology | Issue 1/2018

Abstract

Chronic liver disease, irrespective of cause, can eventually lead to cirrhosis, which is the primary risk factor for developing hepatocellular carcinoma (HCC). In patients with cirrhosis or appropriate risk factors, HCC can be diagnosed by imaging with high specificity using liver imaging reporting and data system v2017, obviating the need for histologic confirmation. Confident recognition of cirrhosis by conventional imaging alone can be challenging, as radiologists are not always provided with the requisite information to determine if the patient has cirrhosis or other risk factors for HCC. Moreover, cirrhosis-associated abnormalities may impair the diagnostic accuracy of imaging for HCC. This article addresses the diagnosis of cirrhosis by non-invasive imaging and the implications of cirrhosis for imaging interpretation and accuracy.

Schuppan D, Afdhal NH (2008) Liver cirrhosis. Lancet 371(9615):838–851. https://doi.org/10.1016/S0140-6736(08)60383-9 CrossRefPubMedPubMedCentral

Tsochatzis EA, Bosch J, Burroughs AK (2014) Liver cirrhosis. Lancet 383(9930):1749–1761. https://doi.org/10.1016/S0140-6736(14)60121-5 CrossRefPubMed

Ge PS, Runyon BA (2016) Treatment of patients with cirrhosis. N Engl J Med 375(8):767–777. https://doi.org/10.1056/NEJMra1504367 CrossRefPubMed

Bedossa P, Poynard T (1996) An algorithm for the grading of activity in chronic hepatitis C. The METAVIR cooperative study group. Hepatology 24(2):289–293. https://doi.org/10.1002/hep.510240201 CrossRefPubMed

Batts KP, Ludwig J (1995) Chronic hepatitis. An update on terminology and reporting. Am J Surg Pathol 19(12):1409–1417CrossRefPubMed

Scheuer PJ (1991) Classification of chronic viral hepatitis: a need for reassessment. J Hepatol 13(3):372–374CrossRefPubMed

Kleiner DE, Brunt EM, Van Natta M, et al. (2005) Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 41(6):1313–1321. https://doi.org/10.1002/hep.20701 CrossRefPubMed

Ishak K, Baptista A, Bianchi L, et al. (1995) Histological grading and staging of chronic hepatitis. J Hepatol 22(6):696–699CrossRefPubMed

Forner A, Llovet JM, Bruix J (2012) Hepatocellular carcinoma. Lancet 379(9822):1245–1255. https://doi.org/10.1016/S0140-6736(11)61347-0 CrossRefPubMed

10.

Yeom SK, Lee CH, Cha SH, Park CM (2015) Prediction of liver cirrhosis, using diagnostic imaging tools. World J Hepatol 7(17):2069–2079. https://doi.org/10.4254/wjh.v7.i17.2069 CrossRefPubMedPubMedCentral

11.

Huber A, Ebner L, Heverhagen JT, Christe A (2015) State-of-the-art imaging of liver fibrosis and cirrhosis: a comprehensive review of current applications and future perspectives. Eur J Radiol Open 2:90–100. https://doi.org/10.1016/j.ejro.2015.05.002 CrossRefPubMedPubMedCentral

12.

Jha P, Poder L, Wang ZJ, et al. (2010) Radiologic mimics of cirrhosis. AJR Am J Roentgenol 194(4):993–999. https://doi.org/10.2214/AJR.09.3409 CrossRefPubMed

13.

Gupta AA, Kim DC, Krinsky GA, Lee VS (2004) CT and MRI of cirrhosis and its mimics. AJR Am J Roentgenol 183(6):1595–1601. https://doi.org/10.2214/ajr.183.6.01831595 CrossRefPubMed

14.

Dodd GD 3rd, Baron RL, Oliver JH 3rd, Federle MP (1999) Spectrum of imaging findings of the liver in end-stage cirrhosis: part I, gross morphology and diffuse abnormalities. AJR Am J Roentgenol 173(4):1031–1036. https://doi.org/10.2214/ajr.173.4.10511173 CrossRefPubMed

15.

Qayyum A, Lee GK, Yeh BM, et al. (2007) Frequency of hepatic contour abnormalities and signs of portal hypertension at CT in patients receiving chemotherapy for breast cancer metastatic to the liver. Clin Imaging 31(1):6–10. https://doi.org/10.1016/j.clinimag.2006.09.028 CrossRefPubMed

16.

Young ST, Paulson EK, Washington K, et al. (1994) CT of the liver in patients with metastatic breast carcinoma treated by chemotherapy: findings simulating cirrhosis. AJR Am J Roentgenol 163(6):1385–1388. https://doi.org/10.2214/ajr.163.6.7992734 CrossRefPubMed

17.

Schreiner SA, Gorman B, Stephens DH (1998) Chemotherapy-related hepatotoxicity causing imaging findings resembling cirrhosis. Mayo Clin Proc 73(8):780–783. https://doi.org/10.4065/73.8.780 CrossRefPubMed

18.

Di Lelio A, Cestari C, Lomazzi A, Beretta L (1989) Cirrhosis: diagnosis with sonographic study of the liver surface. Radiology 172(2):389–392. https://doi.org/10.1148/radiology.172.2.2526349 CrossRefPubMed

19.

Poff JA, Coakley FV, Qayyum A, et al. (2008) Frequency and histopathologic basis of hepatic surface nodularity in patients with fulminant hepatic failure. Radiology 249(2):518–523. https://doi.org/10.1148/radiol.2492072168 CrossRefPubMed

20.

Murakami T, Baron RL, Peterson MS (1996) Liver necrosis and regeneration after fulminant hepatitis: pathologic correlation with CT and MR findings. Radiology 198(1):239–242. https://doi.org/10.1148/radiology.198.1.8539386 CrossRefPubMed

21.

Dachman AH, Ros PR, Goodman ZD, Olmsted WW, Ishak KG (1987) Nodular regenerative hyperplasia of the liver: clinical and radiologic observations. AJR Am J Roentgenol 148(4):717–722. https://doi.org/10.2214/ajr.148.4.717 CrossRefPubMed

22.

Qayyum A, Graser A, Westphalen A, et al. (2004) CT of benign hypervascular liver nodules in autoimmune hepatitis. AJR Am J Roentgenol 183(6):1573–1576. https://doi.org/10.2214/ajr.183.6.01831573 CrossRefPubMed

23.

Rha SE, Lee MG, Lee YS, et al. (2000) Nodular regenerative hyperplasia of the liver in Budd-Chiari syndrome: CT and MR features. Abdom Imaging 25(3):255–258CrossRefPubMed

24.

Casillas C, Marti-Bonmati L, Galant J (1997) Pseudotumoral presentation of nodular regenerative hyperplasia of the liver: imaging in five patients including MR imaging. Eur Radiol 7(5):654–658. https://doi.org/10.1007/BF02742920 CrossRefPubMed

25.

Scott GC, Berman JM, Higgins JL Jr (1997) CT patterns of nodular hepatic and splenic sarcoidosis: a review of the literature. J Comput Assist Tomogr 21(3):369–372CrossRefPubMed

26.

Akhan O, Karaosmanoglu AD, Ergen B (2007) Imaging findings in congenital hepatic fibrosis. Eur J Radiol 61(1):18–24. https://doi.org/10.1016/j.ejrad.2006.11.007 CrossRefPubMed

27.

Futagawa S, Fukazawa M, Horisawa M, et al. (1980) Portographic liver changes in idiopathic noncirrhotic portal hypertension. AJR Am J Roentgenol 134(5):917–923. https://doi.org/10.2214/ajr.134.5.917 CrossRefPubMed

28.

Futagawa S, Fukazawa M, Musha H, et al. (1981) Hepatic venography in noncirrhotic idiopathic portal hypertension. Comparison with cirrhosis of the liver. Radiology 141((2):303–309. https://doi.org/10.1148/radiology.141.2.7291551 CrossRefPubMed

29.

Ghaferi AA, Hutchins GM (2005) Progression of liver pathology in patients undergoing the Fontan procedure: Chronic passive congestion, cardiac cirrhosis, hepatic adenoma, and hepatocellular carcinoma. J Thorac Cardiovasc Surg 129(6):1348–1352. https://doi.org/10.1016/j.jtcvs.2004.10.005 CrossRefPubMed

30.

Wells ML, Fenstad ER, Poterucha JT, et al. (2016) Imaging findings of congestive hepatopathy. Radiographics 36(4):1024–1037. https://doi.org/10.1148/rg.2016150207 CrossRefPubMed

31.

Horowitz JM, Venkatesh SK, Ehman RL, et al. (2017) Evaluation of hepatic fibrosis: a review from the society of abdominal radiology disease focus panel. Abdom Radiol (NY) 42(8):2037–2053. https://doi.org/10.1007/s00261-017-1211-7 CrossRef

32.

Sherman M (2010) Hepatocellular carcinoma: epidemiology, surveillance, and diagnosis. Semin Liver Dis 30(1):3–16. https://doi.org/10.1055/s-0030-1247128 CrossRefPubMed

33.

McGlynn KA, London WT (2005) Epidemiology and natural history of hepatocellular carcinoma. Best Pract Res Clin Gastroenterol 19(1):3–23. https://doi.org/10.1016/j.bpg.2004.10.004 CrossRefPubMed

34.

Ascha MS, Hanouneh IA, Lopez R, et al. (2010) The incidence and risk factors of hepatocellular carcinoma in patients with nonalcoholic steatohepatitis. Hepatology 51(6):1972–1978. https://doi.org/10.1002/hep.23527 CrossRefPubMed

35.

Bruix J, Sherman M, American Association for the Study of Liver D (2011) Management of hepatocellular carcinoma: an update. Hepatology 53(3):1020–1022. https://doi.org/10.1002/hep.24199 CrossRefPubMedPubMedCentral

36.

Caballeria L, Pares A, Castells A, et al. (2001) Hepatocellular carcinoma in primary biliary cirrhosis: similar incidence to that in hepatitis C virus-related cirrhosis. Am J Gastroenterol 96(4):1160–1163. https://doi.org/10.1111/j.1572-0241.2001.03695.x PubMed

37.

European Association for Study of L, European Organisation for R, Treatment of C (2012) EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma. Eur J Cancer 48(5):599–641. https://doi.org/10.1016/j.ejca.2011.12.021 CrossRef

38.

Morgan TR, Mandayam S, Jamal MM (2004) Alcohol and hepatocellular carcinoma. Gastroenterology 127(5 Suppl 1):S87–96CrossRefPubMed

39.

Tansel A, Katz LH, El-Serag HB, et al. (2017) Incidence and determinants of hepatocellular carcinoma in autoimmune hepatitis: a systematic review and meta-analysis. Clin Gastroenterol Hepatol 15(8):1207–1217. https://doi.org/10.1016/j.cgh.2017.02.006 CrossRefPubMed

40.

Yeoman AD, Al-Chalabi T, Karani JB, et al. (2008) Evaluation of risk factors in the development of hepatocellular carcinoma in autoimmune hepatitis: implications for follow-up and screening. Hepatology 48(3):863–870. https://doi.org/10.1002/hep.22432 CrossRefPubMed

41.

Yu JS, Kim KW, Sung KB, Lee JT, Yoo HS (1997) Small arterial-portal venous shunts: a cause of pseudolesions at hepatic imaging. Radiology 203(3):737–742. https://doi.org/10.1148/radiology.203.3.9169697 CrossRefPubMed

42.

Holland AE, Hecht EM, Hahn WY, et al. (2005) Importance of small (< or = 20-mm) enhancing lesions seen only during the hepatic arterial phase at MR imaging of the cirrhotic liver: evaluation and comparison with whole explanted liver. Radiology 237(3):938–944. https://doi.org/10.1148/radiol.2373041364 CrossRefPubMed

43.

Hwang SH, Yu JS, Kim KW, Kim JH, Chung JJ (2008) Small hypervascular enhancing lesions on arterial phase images of multiphase dynamic computed tomography in cirrhotic liver: fate and implications. J Comput Assist Tomogr 32(1):39–45. https://doi.org/10.1097/RCT.0b013e318064c76b CrossRefPubMed

44.

Motosugi U, Ichikawa T, Sou H, et al. (2010) Distinguishing hypervascular pseudolesions of the liver from hypervascular hepatocellular carcinomas with gadoxetic acid-enhanced MR imaging. Radiology 256(1):151–158. https://doi.org/10.1148/radiol.10091885 CrossRefPubMed

45.

Hussain HK, Syed I, Nghiem HV, et al. (2004) T2-weighted MR imaging in the assessment of cirrhotic liver. Radiology 230(3):637–644. https://doi.org/10.1148/radiol.2303020921 CrossRefPubMed

46.

Kim TK, Chung JW, Han JK, et al. (1999) Hepatic changes in benign obstruction of the hepatic inferior vena cava: CT findings. AJR Am J Roentgenol 173(5):1235–1242. https://doi.org/10.2214/ajr.173.5.10541095 CrossRefPubMed

47.

Vilgrain V, Condat B, Bureau C, et al. (2006) Atrophy-hypertrophy complex in patients with cavernous transformation of the portal vein: CT evaluation. Radiology 241(1):149–155. https://doi.org/10.1148/radiol.2411051102 CrossRefPubMed

48.

Lory J, Schweizer W, Blumgart LH, Zimmermann A (1994) The pathology of the atrophy/hypertrophy complex (AHC) of the liver. A light microscopic and immunohistochemical study. Histol Histopathol 9(3):541–554PubMed

49.

Ito K, Mitchell DG, Outwater EK, Blasbalg R (1999) Primary sclerosing cholangitis: MR imaging features. AJR Am J Roentgenol 172(6):1527–1533. https://doi.org/10.2214/ajr.172.6.10350284 CrossRefPubMed

50.

Dodd GD 3rd, Baron RL, Oliver JH 3rd, Federle MP (1999) End-stage primary sclerosing cholangitis: CT findings of hepatic morphology in 36 patients. Radiology 211(2):357–362. https://doi.org/10.1148/radiology.211.2.r99ma49357 CrossRefPubMed

51.

Bader TR, Beavers KL, Semelka RC (2003) MR imaging features of primary sclerosing cholangitis: patterns of cirrhosis in relationship to clinical severity of disease. Radiology 226(3):675–685. https://doi.org/10.1148/radiol.2263011623 CrossRefPubMed

52.

Blachar A, Federle MP, Brancatelli G (2001) Primary biliary cirrhosis: clinical, pathologic, and helical CT findings in 53 patients. Radiology 220(2):329–336. https://doi.org/10.1148/radiology.220.2.r01au36329 CrossRefPubMed

53.

Mitchell DG, Palazzo J, Hann HW, et al. (1992) Mass-like hepatic hypertrophy: MRI findings with histologic correlation. Magn Reson Imaging 10(4):541–547CrossRefPubMed

54.

Brancatelli G, Federle MP, Grazioli L, Golfieri R, Lencioni R (2002) Large regenerative nodules in Budd-Chiari syndrome and other vascular disorders of the liver: CT and MR imaging findings with clinicopathologic correlation. AJR Am J Roentgenol 178(4):877–883. https://doi.org/10.2214/ajr.178.4.1780877 CrossRefPubMed

55.

Brancatelli G, Baron RL, Federle MP, Sparacia G, Pealer K (2009) Focal confluent fibrosis in cirrhotic liver: natural history studied with serial CT. AJR Am J Roentgenol 192(5):1341–1347. https://doi.org/10.2214/AJR.07.2782 CrossRefPubMed

56.

Mwangi I, Hanna RF, Kased N, et al. (2010) Apparent diffusion coefficient of fibrosis and regenerative nodules in the cirrhotic liver at MRI. AJR Am J Roentgenol 194(6):1515–1522. https://doi.org/10.2214/AJR.09.3484 CrossRefPubMed

57.

Ohtomo K, Baron RL, Dodd GD 3rd, et al. (1993) Confluent hepatic fibrosis in advanced cirrhosis: evaluation with MR imaging. Radiology 189(3):871–874. https://doi.org/10.1148/radiology.189.3.8234718 CrossRefPubMed

58.

Choi JY, Lee JM, Sirlin CB (2014) CT and MR imaging diagnosis and staging of hepatocellular carcinoma: part I. Development, growth, and spread: key pathologic and imaging aspects. Radiology 272(3):635–654. https://doi.org/10.1148/radiol.14132361 CrossRefPubMedPubMedCentral

59.

Chernyak V, Tang A, Flusberg M, et al. (2017) LI-RADS(R) ancillary features on CT and MRI. Abdom Radiol (NY). https://doi.org/10.1007/s00261-017-1220-6

60.

Galia M, Taibbi A, Marin D, et al. (2014) Focal lesions in cirrhotic liver: what else beyond hepatocellular carcinoma? Diagn Interv Radiol 20(3):222–228. https://doi.org/10.5152/dir.2014.13184 CrossRefPubMedPubMedCentral

61.

Gerlach JT, Diepolder HM, Zachoval R, et al. (2003) Acute hepatitis C: high rate of both spontaneous and treatment-induced viral clearance. Gastroenterology 125(1):80–88CrossRefPubMed

Title: Cirrhosis and LI-RADS
Authors: Demetrios Papadatos
Kathryn J. Fowler
Ania Z. Kielar
Jennifer Cui
Claude B. Sirlin
Publication date: 01-01-2018
Publisher: Springer US
Published in: Abdominal Radiology / Issue 1/2018
Print ISSN: 2366-004X
Electronic ISSN: 2366-0058
DOI: https://doi.org/10.1007/s00261-017-1425-8

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin

Prof. Florian Limbourg

Prof. Anoop Chauhan

Developed by: Springer Medicine

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits

Illustration of figure on mountain summit/© Orapun / Stock.adobe.com, STEP AAG HeroTeaserCollection image/© Tarek / Generated with AI / Stock.adobe.com, ACC 2024 Pediatric and Congenital Heart Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 Pulmonary Vascular Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 Valvular Heart Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 HF and Cardiomyopathies: Year in Review/© 2024 American College of Cardiology, Woman out walking/© Seventyfour / stock.adobe.com (symbolic image with model), Woman checking smartwatch /© saltdium / stock.adobe.com (symbolic image with model), Cardiac catheterization/© Damian / stock.adobe.com

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 1/2018

LI-RADS technical requirements for CT, MRI, and contrast-enhanced ultrasound

LI-RADS M (LR-M): definite or probable malignancy, not specific for hepatocellular carcinoma

Liver-directed therapy for hepatocellular carcinoma

Letter to the editor

LI-RADS® ancillary features on CT and MRI

Implementation of LI-RADS into a radiological practice

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

Highlights from the ACC 2024 Congress

ACC 2024 Congress Coverage